Afrikaans Afrikaans
en Englishaf Afrikaanssq Albanianar Arabichy Armenianaz Azerbaijanieu Basquebe Belarusianbg Bulgarianca Catalanzh-CN Chinese (Simplified)zh-TW Chinese (Traditional)hr Croatiancs Czechda Danishnl Dutchet Estoniantl Filipinofi Finnishfr Frenchgl Galicianka Georgiande Germanel Greekht Haitian Creoleiw Hebrewhi Hindihu Hungarianis Icelandicid Indonesianga Irishit Italianja Japaneseko Koreanlv Latvianlt Lithuanianmk Macedonianms Malaymt Malteseno Norwegianfa Persianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsw Swahilisv Swedishth Thaitr Turkishuk Ukrainianur Urduvi Vietnamesecy Welshyi Yiddish

Jongste Nuus

FDA-hysbakke hou die uniQure-program vir genterapie vir hemofilie B in

 

Roctavian, potensiële hemofilie 'n gentherapie, kry vars FDA-ondersteuning

 

Hemofilie B Gentherapie AMT-061 Dit het waarskynlik nie lewertumor veroorsaak nie

 

Genterapie SPK-8016 toon vroeë belofte vir erge hemofilie A

 

Terug na bo
Image

Please enable the javascript to submit this form

Oor ons

Ondersteun deur opvoedkundige toekennings van Bayer, BioMarin, CSL Behring, Freeline Therapeutics Limited, Pfizer Inc., Spark Therapeutics en uniQure, Inc.

Noodsaaklike SSL